Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organ transplants
Biotech
LifeMine revived by $188M fundraise backed by Gates and Bezos
After putting its fungus-based platform on ice to focus its dwindling resources on its lead asset, LifeMine has been reinvigorated.
Darren Incorvaia
Aug 6, 2026 6:30am
Thermo Fisher unveils test for dosing of antirejection drug
Feb 27, 2026 5:20am
Terumo inks $1.5B deal for liver transplant developer OrganOx
Aug 25, 2025 11:45am
LifeMine lays off staff to focus on lead immunology asset
Mar 31, 2025 5:26pm
Paragonix's donor organ perfusion system flies kidney commercial
Mar 3, 2025 12:06pm
Liver transplant specialist OrganOx raises $142M
Feb 24, 2025 11:00am
